Grasselli, Giacomo http://orcid.org/0000-0002-1735-1400
Cattaneo, Emanuele
Florio, Gaetano
Ippolito, Mariachiara
Zanella, Alberto
Cortegiani, Andrea
Huang, Jianbo
Pesenti, Antonio
Einav, Sharon
Funding for this research was provided by:
Italian Ministry of Health
Article History
Received: 14 January 2021
Accepted: 5 March 2021
First Online: 20 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Grasselli reports personal fees from Maquet, personal fees from Biotest, personal fees from Pfizer, personal fees from Draeger, personal fees from Fisher&Paykel, personal fees from MSD. Dr. Zanella has patent ES2732104 licensed to AW Technologies and patents US2017348472 and US2017224898 licensed to Fresenius. Dr. Pesenti reports personal fees from Maquet, Novalung/Xenios, Baxter, and Boehringer Ingelheim. Dr. Einav has support from Zoll, Siemens and Medtronic, research funding from Oridion, Diasorin, Haemonetics, participation in multicenter trials for Artisanpharma, Ely Lily, Takeda, Astra Zeneca, Eisai. The other authors declare that they have no competing interests.